We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$706M
AUM Growth
+$54.1M
Cap. Flow
+$46.4M
Cap. Flow %
6.57%
Top 10 Hldgs %
27.23%
Holding
481
New
74
Increased
256
Reduced
106
Closed
22

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$8.37M
2
AAPL icon
Apple
AAPL
+$2.43M
3
TRI icon
Thomson Reuters
TRI
+$2.32M
4
AMZN icon
Amazon
AMZN
+$1.46M
5
MSFT icon
Microsoft
MSFT
+$1.37M

Sector Composition

Rank Sector Weight
1 Technology 13.69%
2 Financials 12.33%
3 Healthcare 10.07%
4 Industrials 8.01%
5 Consumer Discretionary 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
76
Nike
NKE
$63.9B
$2.05M 0.29%
21,866
+6,419
+42% +$550K
PSX icon
77
Phillips 66
PSX
$82.5B
$2.04M 0.29%
19,874
+193
+1% +$19.3K
WEC icon
78
WEC Energy
WEC
$37B
$2.02M 0.29%
21,232
+832
+4% +$75K
LEN icon
79
Lennar Class A
LEN
$21.1B
$1.98M 0.28%
36,558
-7,013
-16% -$342K
CELG
80
DELISTED
Celgene Corp
CELG
$1.97M 0.28%
19,817
-593
-3% -$56.3K
COF icon
81
Capital One
COF
$130B
$1.91M 0.27%
20,946
-3,613
-15% -$325K
VUG icon
82
Vanguard Growth ETF
VUG
$216B
$1.88M 0.27%
67,998
QQQ icon
83
Invesco QQQ Trust
QQQ
$445B
$1.88M 0.27%
9,953
-476
-5% -$90.2K
TMO icon
84
Thermo Fisher Scientific
TMO
$214B
$1.88M 0.27%
6,454
+988
+18% +$283K
VOT icon
85
Vanguard Mid-Cap Growth ETF
VOT
$19.1B
$1.87M 0.26%
12,629
-1,161
-8% -$174K
MRSH
86
Marsh
MRSH
$91.7B
$1.85M 0.26%
18,524
+1,026
+6% +$103K
OXY icon
87
Occidental Petroleum
OXY
$53.6B
$1.83M 0.26%
41,222
+2,133
+5% +$101K
MCHP icon
88
Microchip Technology
MCHP
$41.1B
$1.83M 0.26%
39,412
+2,956
+8% +$134K
IWN icon
89
iShares Russell 2000 Value ETF
IWN
$14.5B
$1.76M 0.25%
14,782
+496
+3% +$58.6K
CVS icon
90
CVS Health
CVS
$140B
$1.76M 0.25%
27,904
-5,209
-16% -$309K
GD icon
91
General Dynamics
GD
$106B
$1.76M 0.25%
9,633
+101
+1% +$18.8K
DLR icon
92
Digital Realty Trust
DLR
$71.5B
$1.72M 0.24%
13,284
+923
+7% +$112K
LOW icon
93
Lowe's Companies
LOW
$122B
$1.72M 0.24%
15,667
+5,928
+61% +$626K
BAX icon
94
Baxter International
BAX
$12.6B
$1.71M 0.24%
19,593
+811
+4% +$69.2K
DAL icon
95
Delta Air Lines
DAL
$58.8B
$1.71M 0.24%
29,734
-7,475
-20% -$443K
HCA icon
96
HCA Healthcare
HCA
$92.8B
$1.69M 0.24%
14,025
-2,492
-15% -$322K
TSN icon
97
Tyson Foods
TSN
$21.5B
$1.68M 0.24%
19,501
+9,410
+93% +$800K
ORCL icon
98
Oracle
ORCL
$346B
$1.68M 0.24%
30,464
+7,983
+36% +$441K
COST icon
99
Costco
COST
$429B
$1.66M 0.23%
5,749
+1,144
+25% +$322K
CB icon
100
Chubb
CB
$141B
$1.65M 0.23%
10,237
+306
+3% +$47.3K

Similar funds

Corient Capital Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Corient Capital Partners held 481 positions worth $706M, up 8.3% from $652M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Corient Capital Partners deployed $46.4M of net new capital in Q3 2019, opening 74 new positions and adding to 256 existing holdings. Its largest new stake was Thomson Reuters: 32,696 shares worth $2.3M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 Value ETF, an estimated $3.68M trimmed.

  • Corient Capital Partners's largest Q3 2019 buy was Thomson Reuters: 32,696 shares worth $2.3M.
  • Corient Capital Partners added most to iShares Core S&P 500 ETF in Q3 2019, an estimated $8.37M increase.
  • Corient Capital Partners's biggest Q3 2019 reduction was Vanguard S&P 500 Value ETF, cutting an estimated $3.68M.
  • Corient Capital Partners fully exited Foot Locker in Q3 2019, selling an estimated $1.39M.
  • Corient Capital Partners's ten largest holdings make up 27% of its $706M portfolio in Q3 2019.
  • Corient Capital Partners opened 74 new positions and closed 22 in Q3 2019.
  • Corient Capital Partners's portfolio value rose 8.3% quarter-over-quarter to $706M.

Based on Corient Capital Partners's 13F filing for Q3 2019, filed 6 Nov 2019.